12 /100
LOW RISK
Score updated May 29, 2026

BEAM — Beam Therapeutics Inc. Dilution Risk Tracker

Track BEAM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BEAM — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BEAM.
🔔 Track BEAM — Get forecast alerts →

💹 Market Data

Market Cap$3.37B
Shares Outstanding102.88M
Float87.97M
Cash$1.21B
Debt$250.82M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 9.7% shares (2025Q4 vs prior)
244 institutional holders · 121.12M shares
#1 FARALLON CAPITAL MANAGEMENT LLC 20.13M shares
#2 ARK Investment Management LLC 12.47M shares
#3 FMR LLC 11.91M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest20.94M
Days to Cover9.5
% of Float23.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BEAM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BEAM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BEAM
📊 BEAM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BEAM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.